Singular Genomics Systems Investor Relations Material
Latest events
Q2 2024
Singular Genomics Systems
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Singular Genomics Systems Inc
Access all reports
Singular Genomics Systems Inc. is a life sciences technology company focused on developing next-generation sequencing (NGS) platforms and genomic analysis solutions. The company’s flagship products include the G4 Sequencing Platform, designed to deliver fast, accurate, and flexible sequencing for research and clinical applications. Singular Genomics aims to support areas such as oncology, immunology, and inherited disease research. Singular Genomics is headquartered in San Diego, California, and its shares are listed on the NASDAQ.
Latest articles
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
Ticker symbol
OMIC
Country
🇺🇸 United States